Skip to content
Screener

Becton, Dickinson and Company BDX Loss Contingency Accrual

Loss Contingency Accrual at other companies

Solventum logo
SolventumSOLV
$235M+1,019%
Medtronic logo
MedtronicMDT

Other financials

Income statement

See full
Revenue$5.0B-9.5%
Gross profit$2.3B-12.1%
Operating income$663.0M-24.8%
Net income$377.0M-34.3%
EPS (diluted)$1.64-18.0%

Balance sheet

See full
Cash & equivalents$708.0M-11.3%
Total debt$13.5B-22.9%
Total equity$24.4B-4.1%
Total assets$50.7B-7.6%

Cash flow

See full
Operating cash flow$776.0M-51.1%
CapEx$143.0M-24.3%
Free cash flow$633.0M-54.7%

Valuation

See full
Market cap$48.79B-1.3%
Enterprise value$61.59B-6.9%
P/E51.9×+20.7×
P/S2.3×-0.1×

Profitability

See full
Gross margin46.4%+1.7pp
Operating margin9.6%-1.7pp
Net margin4.5%-3.2pp
FCF margin13.1%

Returns & leverage

See full
Return on equity3.8%-2.4pp
Debt / equity0.6×-0.1×
Current ratio0.9×-0.2×

Where this comes from

Reported directly by Becton, Dickinson and Company in its filing.

Tagged under the XBRL concept us-gaap:LossContingencyAccrualAtCarryingValue.

The source filing: Becton, Dickinson and Company’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0000010795-26-000026

Accruals for the Company’s product liability claims and certain other legal matters, which are discussed above, as well as legal defense costs for certain of these matters, amounted to approximately $1.7 billion and $1.8 billion at March 31, 2026 and September 30, 2025, respectively. A substantial portion of these accruals are recorded within Deferred Income Taxes and Other Liabilities and the remainder are recorded within Total Current Liabilities on the Company’s condensed consolidated balance sheets. The Company’s accruals for product liability and certain other legal matters as of March 31, 2026, as compared with September 30, 2025, primarily reflected payments of settlements and legal fees, partially offset by an increase in accruals for certain matters.

Item 1. Financial Statements (Unaudited)

FAQ

What is Becton, Dickinson and Company's loss contingency accrual?
Becton, Dickinson and Company (BDX) reported loss contingency accrual of $1.7B in Q1 2026.
What is the long-term trend for Becton, Dickinson and Company's loss contingency accrual?
Over 3 years (2021 to 2025), Becton, Dickinson and Company's loss contingency accrual has grown at a -10.4% compound annual growth rate (CAGR), from $2.5B to $1.8B.

Ask your AI about Becton, Dickinson and Company's loss contingency accrual.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude